Cingulate develops once-a-day ADHD and anxiety medicines using its proprietary drug delivery platform. It last closed at $4.51 on Nov 20, down 14.26% on the day. The next earnings report for CING is expected around Wed, Mar 17, 2027. For the quarter ended Sep 2026, CING reported EPS of -$0.53. Over its last 8 reports the stock moved an average of 10.8% the session after earnings. Over the last 12 months CING insiders bought $657K of stock on the open market and sold $0, according to SEC Form 4 filings.
AI Auto Pilots
Is CING in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold CING.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on CINGStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
CING · as of the Nov 20 close · updated each morning
Downtrend
The stock is 5% below its 20 day and 7% below its 50 day average. It is 19% below its 200 day average, so the longer trend is down. Momentum is improving (RSI 47). The nearest support is the swing low (Jul 28) at $4.25, and the nearest resistance the Pivot at $4.72.
Short trendBearish
Long trendBearish
MomentumImproving
StretchNormal
VolatilityHigh, 9.9%/day
Key levels
$11.8952 week high+163.6%
$5.35200 day average+18.6%
$5.03Pivot R1+11.5%
$4.92100 day average+9.1%
$4.84Swing high (Nov 10)+7.3%
$4.8150 day average+6.7%
$4.7420 day average+5.1%
$4.72Pivot+4.7%
$4.51Last close
$4.25Swing low (Jul 28)−5.8%
$4.19Pivot S1−7.1%
$3.1652 week low−29.9%
Indicators
RSI (14)
47.31
Middle of its range
Neutral
MACD
-0.04
Above its signal line
Bullish
Stochastic
71.4
Middle of its range
Neutral
ADX (14)
16.3
No clear trend
Williams %R
-53.2
Oversold below −80, overbought above −20
Neutral
CCI (20)
-6.5
Oversold below −100, overbought above 100
Neutral
Rate of change
+5.9%
Change over 10 sessions
Bullish
ATR (14)
$0.45
Typical daily range, 9.9% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend
Short trendBearish
Long trendBearish
MomentumWeak
StretchNormal
VolatilityNormal, 18.9%/day
Key levels
$11.8952 week high+163.6%
$5.35200 day average+18.6%
$5.03Pivot R1+11.5%
$4.92100 day average+9.1%
$4.84Swing high (Nov 10)+7.3%
$4.8150 day average+6.7%
$4.7420 day average+5.1%
$4.72Pivot+4.7%
$4.51Last close
$4.25Swing low (Jul 28)−5.8%
$4.19Pivot S1−7.1%
$3.1652 week low−29.9%
Indicators
RSI (14)
45.43
Middle of its range
Neutral
MACD
-0.17
Below its signal line
Bearish
Stochastic
18.4
Near the bottom of its range
Oversold
ADX (14)
14.8
No clear trend
Williams %R
-62.5
Oversold below −80, overbought above −20
Neutral
CCI (20)
-83.8
Oversold below −100, overbought above 100
Neutral
Rate of change
−10.2%
Change over 10 sessions
Bearish
ATR (14)
$0.85
Typical daily range, 18.9% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for CING
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how CING did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow CING usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for CINGHow many large options trades hit CING, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in CING in the last 90 days.
From SEC Form 4 filings by CING's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether CING is in one of them and how their past CING trades turned out.
Cingulate is a biopharmaceutical company based in Kansas City, Kansas. It uses its proprietary Precision Timed Release drug delivery platform to develop medicines that release doses at set times, so patients can take them one time a day. Its lead candidate, CTx-1301, is a stimulant for attention deficit hyperactivity disorder and is under review by the U.S. Food and Drug Administration. The company is also developing a buspirone tablet for anxiety, with patients, physicians and payers as its intended users.